LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

Quanterix Corp

Închisă

SectorSănătate

6.67 6.21

Rezumat

Modificarea prețului

24h

Curent

Minim

6.05

Maxim

6.78

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+19.24% upside

Dividende

By Dow Jones

Următoarele câștiguri

2 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

27M

265M

Deschiderea anterioară

0.46

Închiderea anterioară

6.67

Sentimentul știrilor

By Acuity

17%

83%

19 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 feb. 2026, 22:04 UTC

Câștiguri

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 feb. 2026, 23:55 UTC

Market Talk

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 feb. 2026, 23:40 UTC

Achiziții, Fuziuni, Preluări

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 feb. 2026, 23:37 UTC

Market Talk

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 feb. 2026, 23:32 UTC

Câștiguri

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 feb. 2026, 23:19 UTC

Achiziții, Fuziuni, Preluări

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 feb. 2026, 23:18 UTC

Achiziții, Fuziuni, Preluări

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 feb. 2026, 23:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

26 feb. 2026, 23:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 feb. 2026, 23:01 UTC

Achiziții, Fuziuni, Preluări

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb. 2026, 23:00 UTC

Achiziții, Fuziuni, Preluări

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb. 2026, 23:00 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 feb. 2026, 22:55 UTC

Achiziții, Fuziuni, Preluări

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb. 2026, 22:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26 feb. 2026, 22:43 UTC

Market Talk

RBA Hike In March Is Being Underpriced -- Market Talk

26 feb. 2026, 22:33 UTC

Achiziții, Fuziuni, Preluări

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 feb. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 feb. 2026, 22:13 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 feb. 2026, 21:59 UTC

Câștiguri

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 feb. 2026, 21:58 UTC

Achiziții, Fuziuni, Preluări

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 feb. 2026, 21:49 UTC

Câștiguri

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 feb. 2026, 21:45 UTC

Câștiguri

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 feb. 2026, 21:44 UTC

Câștiguri

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 feb. 2026, 21:44 UTC

Câștiguri

Coles Expects Market to Remain Highly Competitive

26 feb. 2026, 21:44 UTC

Câștiguri

Coles Says Supermarket Customers Remain Value Oriented

26 feb. 2026, 21:43 UTC

Câștiguri

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 feb. 2026, 21:43 UTC

Câștiguri

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 feb. 2026, 21:42 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 feb. 2026, 21:41 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

19.24% sus

Prognoză pe 12 luni

Medie 7.5 USD  19.24%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

19 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat